<DOC>
	<DOC>NCT01896583</DOC>
	<brief_summary>This trial will evaluate the effect of ASP7147 on daily abdominal pain due to IBS-D during 4 weeks of treatment. It will also evaluate safety and tolerability in patients with IBS-D over the 4-week treatment period.</brief_summary>
	<brief_title>A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Ability to provide written informed consent Men or women aged 1875 years Patient has IBS with diarrhea (IBSD) Ability to communicate with the investigator IBS with constipation (IBSC) or mixed IBS (IBSM) Other significant disease or condition that may interfere with trial completion Untreated lactose intolerance History of alcohol or drug abuse in past two years Participation in other clinical trials within prior month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>